pd 153035 has been researched along with Thyroid Neoplasms in 1 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| La Pietra, V | 1 |
| Sartini, S | 1 |
| Botta, L | 1 |
| Antonelli, A | 1 |
| Ferrari, SM | 1 |
| Fallahi, P | 1 |
| Moriconi, A | 1 |
| Coviello, V | 1 |
| Quattrini, L | 1 |
| Ke, YY | 1 |
| Hsing-Pang, H | 1 |
| Da Settimo, F | 1 |
| Novellino, E | 1 |
| La Motta, C | 1 |
| Marinelli, L | 1 |
1 other study available for pd 153035 and Thyroid Neoplasms
| Article | Year |
|---|---|
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors.
Topics: Antineoplastic Agents; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Dose-Respons | 2018 |